TrianglePUBLICATIONS · 7525883
Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 1994 Nov
- First author
- Roth BJ
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Roth BJ
- type
- Author
- name
- Dreicer R
- type
- Author
- name
- Einhorn LH
- type
- Author
- name
- Neuberg D
- type
- Author
- name
- Johnson DH
- type
- Author
- name
- Smith JL
- type
- Author
- name
- Hudes GR
- type
- Author
- name
- Schultz SM
- type
- Author
- name
- Loehrer PJ
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Roth BJ
- type
- Author
- name
- Dreicer R
- type
- Author
- name
- Einhorn LH
- type
- Author
- name
- Neuberg D
- type
- Author
- name
- Johnson DH
- type
- Author
- name
- Smith JL
- type
- Author
- name
- Hudes GR
- type
- Author
- name
- Schultz SM
- type
- Author
- name
- Loehrer PJ
- type
- Author
- bibliography ids
- nci-bib-6145a8866ac68e7f5de1dc35
- book metadata
- content sha256
- 5abc96ebc0b8d63067d799a443c9c651d83627a9a77e2e3b84f61b5f6cf743f7
- document type
- citation
- dois
- 10.1200/JCO.1994.12.11.2264
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:7525883
- immutable id
- pubmed:7525883@5abc96ebc0b8d63067d799a443c9c651d83627a9a77e2e3b84f61b5f6cf743f7
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 11
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2264-70
- volume
- 12
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 7525883
- provenance
- batch id
- 0195e80d659ca3142556
- provider
- NCBI PubMed ESummary
- record sha256
- f4c7c3bd67945fae61c7d23929e868ea495935ea86bb72f72eae4d2dbd7f2385
- response sha256
- 021698996c455bb1930ebf197fc7e88fce61693e192449206cc5457c0644e062
- retrieved at
- 2026-09-09T23:45:16.849437+00:00
- publication date
- display
- 1994 Nov
- precision
- month
- year
- 1994
- publication types
- Clinical Trial
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/7525883/
- title
- Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group.
Preserved source evidence · Not medical advice